About: Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1997 (uk) im Mai 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1997 (ast) scientific article published on 01 May 1997 (en)
publication date	wds:Q73368699-AD051E1A-69D2-40D6-9776-4B21AEB3DE34
publication date	1997-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73368699-60DE8B2A-1AEB-4AAB-A057-F73AE8ED5F03
language of work or name	English
author name string	wds:Q73368699-031FAED3-99E4-4BBE-BA91-8A68D2A1271E wds:Q73368699-27FF8438-C2EA-454D-BFF8-274DCC2A84C0 wds:Q73368699-3935FFB5-B2BF-43E1-BE8E-2ACB0CA47842 wds:Q73368699-589347B8-97DD-490D-899D-CCFEC7C75C4D wds:Q73368699-81D89FBB-7A07-4E0E-808A-78F2CE60241F wds:Q73368699-A811649D-923D-4712-8B10-B682708EFFF1 wds:Q73368699-BDDE1B83-45A4-4EFC-A4CE-93D93A959A19 wds:Q73368699-C643CB4C-684F-4EC6-9189-916C6BB8241D wds:Q73368699-EC4287DA-8A7B-4ECB-99DB-B2131D998446
author name string	F Eschwege P Rougier D G Gonzalez M van Glabbeke D Peiffert H Bartelink J F Bosset M Pierart F Roelofsen
rdfs:label	Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and (en) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and (nl)
skos:prefLabel	Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and (en) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and (nl)
name	Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and (en) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and (nl)
title	wds:Q73368699-E1C9331C-CA4F-4E88-B460-773CDE036220
title	Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups (en)
page(s)	wds:Q73368699-FA650E03-F1AF-4A38-8F88-2A8F3544560B
page(s)	2040-2049
instance of	wds:Q73368699-E354AE01-3982-45DE-A2DB-16E275B20487
instance of	scholarly article
uses	wds:Q73368699-694F7EAD-F31B-4A95-AE6A-2FE31D4B1716
uses	randomized experiment
main subject	wds:Q73368699-609BDB2B-AACA-4961-92A0-474A49A59C5F wds:Q73368699-BCAAC6B4-80A8-4CA6-AC38-66144EDB268E
main subject	chemotherapy phase III clinical trial
PubMed ID	wds:Q73368699-1EEC6DB1-908B-42D9-B8D8-007B8F1C01B2
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9164216
PubMed ID	9164216
published in	wds:Q73368699-92AF9AA9-EDF6-4734-AD09-2094F4799341
published in	Journal of Clinical Oncology
issue	wds:Q73368699-45593C4D-7DB5-495A-8A79-05095948F9DD
volume	wds:Q73368699-77A1568F-DEF7-45E4-ADA0-26FE833E4812
issue	5
volume	15
DOI	wds:Q73368699-DA43572F-DAAC-49FC-A337-6428FFAA3B1F
DOI	http://dx.doi.org/10.1200/JCO.1997.15.5.2040
DOI	10.1200/JCO.1997.15.5.2040
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73368699
is cites work of	Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: results of a phase II study Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy Prognostic factors for squamous cell cancer of the anal canal Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal Novel techniques in the delivery of radiation in pediatric oncology Update on treatment advances in combined-modality therapy for anal and rectal carcinomas Cancers of the anal canal and anal margin 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal Disparities in receipt of radiotherapy and survival by age, sex, and race among patients with non-metastatic squamous cell carcinoma of the anus Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin Intensity-modulated radiotherapy for squamous cell carcinoma of the anal canal: efficacy of a low daily dose to clinically negative regions Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial Recent advances in gastrointestinal oncology--updates and insights from the 2009 annual meeting of the American society of clinical oncology Treatment of anal carcinoma in the elderly: feasibility and outcome of radical radiotherapy with or without concomitant chemotherapy Multimodality therapy in penile cancer: when and which treatments? Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients Squamous cell carcinoma of the anal canal Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome Efficacy and toxicity of chemoradiation in patients with anal cancer--a retrospective analysis Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal Cancer of the anal canal. Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer? Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience. Intensity-Modulated Radiation Therapy vs. 3D Conformal Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal Combined surgery and chemoradiation as a treatment for the Buschke-Löwenstein tumour Interstitial high-dose rate brachytherapy as boost for anal canal cancer High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study Twenty-year experience in the management of squamous cell anal canal carcinoma with interstitial brachytherapy Anal adenocarcinoma requires prophylactic inguinal nodal treatment: Results from a single Chinese institution Can we omit prophylactic inguinal nodal irradiation in anal cancer patients? Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy Reduced radiation dose for elective nodal irradiation in node-negative anal cancer: back to the roots?

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software